Johnson & Johnson (JNJ)
NYSE: JNJ · IEX Real-Time Price · USD
146.03
-0.41 (-0.28%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Johnson & Johnson Employees
Johnson & Johnson had 131,900 employees as of December 31, 2023. The number of employees decreased by 20,800 or -13.62% compared to the previous year.
Employees
131,900
Change (1Y)
-20,800
Growth (1Y)
-13.62%
Revenue / Employee
$620,136
Profits / Employee
$291,706
Market Cap
351.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Dec 31, 2022 | 152,700 | 11,000 | 7.76% |
Dec 31, 2021 | 141,700 | 7,200 | 5.35% |
Dec 31, 2020 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | 132,200 | -2,900 | -2.15% |
Dec 30, 2018 | 135,100 | 1,100 | 0.82% |
Dec 31, 2017 | 134,000 | 7,600 | 6.01% |
Dec 31, 2016 | 126,400 | -700 | -0.55% |
Dec 31, 2015 | 127,100 | 600 | 0.47% |
Dec 28, 2014 | 126,500 | -1,600 | -1.25% |
Dec 29, 2013 | 128,100 | 500 | 0.39% |
Dec 30, 2012 | 127,600 | 9,700 | 8.23% |
Dec 31, 2011 | 117,900 | 3,900 | 3.42% |
Dec 31, 2010 | 114,000 | -1,500 | -1.30% |
Dec 31, 2009 | 115,500 | -3,200 | -2.70% |
Dec 28, 2008 | 118,700 | -500 | -0.42% |
Dec 30, 2007 | 119,200 | -3,000 | -2.45% |
Dec 31, 2006 | 122,200 | 6,600 | 5.71% |
Dec 31, 2005 | 115,600 | 5,600 | 5.09% |
Dec 31, 2004 | 110,000 | -1,000 | -0.90% |
Dec 28, 2003 | 111,000 | 3,000 | 2.78% |
Dec 29, 2002 | 108,000 | 6,000 | 5.88% |
Dec 30, 2001 | 102,000 | 1,000 | 0.99% |
Dec 31, 2000 | 101,000 | 3,200 | 3.27% |
Dec 31, 2000 | 97,800 | 4,700 | 5.05% |
Dec 31, 1999 | 93,100 | 2,600 | 2.87% |
Dec 28, 1997 | 90,500 | 1,200 | 1.34% |
Dec 29, 1996 | 89,300 | 7,000 | 8.51% |
Dec 31, 1995 | 82,300 | 800 | 0.98% |
Dec 31, 1995 | 81,500 | -100 | -0.12% |
Dec 31, 1994 | 81,600 | -3,300 | -3.89% |
Dec 31, 1993 | 84,900 | 2,200 | 2.66% |
Dec 31, 1991 | 82,700 | 500 | 0.61% |
Dec 31, 1990 | 82,200 | -900 | -1.08% |
Dec 31, 1989 | 83,100 | 1,800 | 2.21% |
Dec 31, 1988 | 81,300 | 3,100 | 3.96% |
Dec 31, 1987 | 78,200 | 1,100 | 1.43% |
Dec 31, 1986 | 77,100 | 2,200 | 2.94% |
Dec 31, 1985 | 74,900 | 700 | 0.94% |
Dec 31, 1984 | 74,200 | -3,200 | -4.13% |
Dec 31, 1983 | 77,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
JNJ News
- 16 hours ago - CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study - PRNewsWire
- 4 days ago - Cancer victims lose bid to block proposed J&J talc bankruptcy - Reuters
- 4 days ago - Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients - PRNewsWire
- 4 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 5 days ago - Lawyers for Johnson & Johnson's Ovarian Cancer Victims React to SCOTUS Decision in Purdue - Business Wire
- 11 days ago - Johnson & Johnson Completes Acquisition of Proteologix, Inc. - Business Wire
- 12 days ago - Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of moderately to severely active Crohn's disease - PRNewsWire
- 12 days ago - More than 60 Law Firms Oppose J&J Prepack Bankruptcy Scheme - Business Wire